Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Edelmann

Showing results (11-20 of 218) with videos related to

Pageof 22
Sort By:
JAMA|July 11, 2013
Aldosterone inhibition in patients with heart failure with preserved ejection fraction--replyFrank Edelmann, Rolf Wachter, Burkert Pieske
Cardiac Failure Review|April 8, 2020
Suppression of Tumourigenicity 2 in Heart Failure With Preserved Ejection FractionVeronika Zach, Felix Lucas Bähr, Frank Edelmann
BMC Cardiovascular Disorders|September 11, 2020
Phosphodiesterase 5 inhibitor sildenafil in patients with heart failure with preserved ejection fraction and combined pre- and postcapillary pulmonary hypertension: a randomized open-label pilot studyEvgeny Belyavskiy, Artem Ovchinnikov, Alexandra Potekhina, et al.
Journal of the American College of Cardiology|March 12, 2016
Benefit of Exercise in Atrial Fibrillation: Diastolic Function Matters!Martin Halle, Volker Adams, Frank Edelmann, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|July 18, 2015
Myocardial hypertrophy and its role in heart failure with preserved ejection fractionFrank R Heinzel, Felix Hohendanner, Ge Jin, et al.
Deutsches Arzteblatt International|March 13, 2018
Chronic Heart FailureFrank Edelmann, Christoph Knosalla, Klaus Mörike, et al.
ESC Heart Failure|April 12, 2024
Transition from asymptomatic to symptomatic systolic chronic heart failure: rationale and design of TransitionCHFAnja Sandek, Frank Edelmann, Christoph Gertler, et al.
Journal of the American College of Cardiology|August 2, 2014
The best treatment approach to pre-clinical diastolic dysfunction?: think about exercise training!Axel Pressler, Silja Schwarz, Jeff Christle, et al.
Biopsychosocial Medicine|October 7, 2020
Higher galectin-3 levels are independently associated with lower anxiety in patients with risk factors for heart failureMonika Sadlonova, Thomas Meyer, Lutz Binder, et al.
Psychoneuroendocrinology|December 30, 2018
Higher plasma levels of CT-proAVP are linked to less anxiety in men but not women with cardiovascular risk factors: Results from the observational Diast-CHF studyMonika Sadlonova, Thomas Meyer, Lutz Binder, et al.
Pageof 22

Showing results (11-20 of 218) with videos related to

Sort By:
Pageof 22
JAMA|July 11, 2013
Aldosterone inhibition in patients with heart failure with preserved ejection fraction--replyFrank Edelmann, Rolf Wachter, Burkert Pieske
Cardiac Failure Review|April 8, 2020
Suppression of Tumourigenicity 2 in Heart Failure With Preserved Ejection FractionVeronika Zach, Felix Lucas Bähr, Frank Edelmann
BMC Cardiovascular Disorders|September 11, 2020
Phosphodiesterase 5 inhibitor sildenafil in patients with heart failure with preserved ejection fraction and combined pre- and postcapillary pulmonary hypertension: a randomized open-label pilot studyEvgeny Belyavskiy, Artem Ovchinnikov, Alexandra Potekhina, et al.
Journal of the American College of Cardiology|March 12, 2016
Benefit of Exercise in Atrial Fibrillation: Diastolic Function Matters!Martin Halle, Volker Adams, Frank Edelmann, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|July 18, 2015
Myocardial hypertrophy and its role in heart failure with preserved ejection fractionFrank R Heinzel, Felix Hohendanner, Ge Jin, et al.
Deutsches Arzteblatt International|March 13, 2018
Chronic Heart FailureFrank Edelmann, Christoph Knosalla, Klaus Mörike, et al.
ESC Heart Failure|April 12, 2024
Transition from asymptomatic to symptomatic systolic chronic heart failure: rationale and design of TransitionCHFAnja Sandek, Frank Edelmann, Christoph Gertler, et al.
Journal of the American College of Cardiology|August 2, 2014
The best treatment approach to pre-clinical diastolic dysfunction?: think about exercise training!Axel Pressler, Silja Schwarz, Jeff Christle, et al.
Biopsychosocial Medicine|October 7, 2020
Higher galectin-3 levels are independently associated with lower anxiety in patients with risk factors for heart failureMonika Sadlonova, Thomas Meyer, Lutz Binder, et al.
Psychoneuroendocrinology|December 30, 2018
Higher plasma levels of CT-proAVP are linked to less anxiety in men but not women with cardiovascular risk factors: Results from the observational Diast-CHF studyMonika Sadlonova, Thomas Meyer, Lutz Binder, et al.
Pageof 22